Fachliteratur Gastroenterologie: Hepatitis

Fr | De

Feedback | Impressum | Sitemap

Keine Artikel ausgewählt!

Warenkorb

Sie sind hier: Fachliteratursuche » Leber » Hepatitis

07. Oktober 2026

Abklärungen / Diagnostik

Therapien

Guidelines

Fortbildung

News / Journalscreening

Schrift:

Seite 1 von 4459


	Artikel 1 - 20 / 89179

	The impact of pretreatment HBs-Ag levels on response to interferon therapy in chronic hepatitis D patients. Infect Dis Now Kiliç S, Taha A, Yalniz M, Halil Bahçecio. PMID: 42838275 [PubMed - as supplied by publisher]
	Optimal Corticosteroid Use in Patients With Severe Alcohol-Associated Hepatitis: A Systematic Review and Meta-Analysis. Clin Transl Gastroenterol Elmustafa F, Sideeg A, Tyagi M, Bhagavathula AS, Pagadala M, Arab JP, Singal AK. PMID: 42837656 [PubMed - as supplied by publisher]
	Depression and medication adherence among chronic hepatitis B patients receiving resilience-based care versus standard care during antiviral therapy: a retrospective cohort study. Front Med (Lausanne) Yang X, Zhao P, Zhang L, Fang C. PMID: 42834913 [PubMed]
	Finite Versus Indefinite Nucleos(t)ide Analogue Therapy in HBeAgâ€‘Negative Chronic Hepatitis B: Metaâ€‘Analysis of Randomized Trials. J Viral Hepat Gomez DP, Hababag WF. PMID: 42834661 [PubMed - indexed for MEDLINE]
	Trends in Hepatitis D Virus Prevalence Among HBsAg-Positive Individuals With and Without HIV in Italy: A Converging Epidemiology. Liver Int Puoti M, Tavelli A, Brancaccio G, Quaranta MG, Tosti ME, Gaeta GB, Kondili LA, d'Arminio Monforte A, PITER, MASTER and ICONA Study Groups. PMID: 42834655 [PubMed - indexed for MEDLINE]
	Direct-Acting Antiviral Therapy in Patients With Hepatocellular Carcinoma Receiving Non-Curative Treatment: High Sustained Virological Response Rates and Preservation of Liver Functional Reserve. J Viral Hepat Sato S, Yamaguchi M, Nago H, Kato Y, Om R, Terai Y, Kita Y, Ikeda Y, Sato S, Murata A, Shimada Y, Genda T. PMID: 42834589 [PubMed - indexed for MEDLINE]
	Acute autoimmune hepatitis diagnosed concurrently with human immunodeficiency virus. BMJ Case Rep Lennox G, Arnaout A, Hamzah L, Singanayagam A. PMID: 42833839 [PubMed - indexed for MEDLINE]
	A comparative analysis of the prevalence of antibodies to the hepatitis E virus (Hepeviridae: Paslahepevirus) among residents of the Amur Region with different levels of zoonotic risk of infection. Vopr Virusol Kichatova VS, Zotova AV, Potemkin IA, Lopatukhina MA, Mobarhan FA, Malinnikova EY, Samokhvalov SV, Kurganova OP, Kyuregyan KK, Akimkin VG, Mikhailov MI. PMID: 42831810 [PubMed - indexed for MEDLINE]
	Awareness regarding the epidemiology, prevention, treatment, and consequences of viral hepatitis among a predominantly young adult population in the Podillia region (Ukraine): a cross-sectional study. Prev Med Rep Paliy I, Palii D, Melashchenko S, Voinalovych O, Haiduk O, Ksenchyn O, Chernova I. PMID: 42830911 [PubMed]
	Becoming Physically Active and Risks of Mortality and Liver-Related Events in Adults With Chronic Hepatitis B: A Nationwide Cohort Study. J Viral Hepat Song BG, Lee M, Cho J, Gwak GY, Kang D, Sinn DH. PMID: 42830566 [PubMed - indexed for MEDLINE]
	THE ROLE OF CELL THERAPY IN THE COMPREHENSIVE TREATMENT OF CHRONIC HEPATITIS C-RELATED LIVER CIRRHOSIS. Georgian Med News Astrakhanov A, Amanzholkyzy A, Saparbayev S, Kurmangazin M, Iskakova A, Nurlanova G. PMID: 42830076 [PubMed - indexed for MEDLINE]
	DETECTION OF HEPATITIS B AND C VIRAL INFECTION AMONG CHILDREN WITH ACUTE LEUKAEMIA. Georgian Med News Hussein S, Ahmed H, Ahmed A. PMID: 42830066 [PubMed - indexed for MEDLINE]
	Therapeutic, preventive, and pathogenetic advances in viral hepatitis. Front Cell Infect Microbiol Jiang H, Zhang YF, Zhang RC, Xing YN. PMID: 42828159 [PubMed - indexed for MEDLINE]
	PYHIN proteins: guardians or contributors to hepatitis B virus pathogenesis? Front Immunol He WQ, Li M, Li JF, Zhang LT. PMID: 42828128 [PubMed - indexed for MEDLINE]
	Exploring the independent factors influencing prolonged QTc intervals in patients with acute-on-chronic liver failure caused by hepatitis B. Medicine (Baltimore) Zhang R, Gao H, Fu M, Li J, Zhou M, Feng Y, Liu J, Zhao Y, He Y. PMID: 42826329 [PubMed - indexed for MEDLINE]
	Efficacy and safety of an 8-week bemnifosbuvir and ruzasvir regimen in chronic hepatitis C: Results from a Phase 2 study. Hepatology Jucov A, Conway B, Feld JJ, Hamid S, Ermacicova E, Iliescu L, Belanger B, Lynch S, Huang Q, Zhou XJ, Horga A, Lawitz E. PMID: 42826065 [PubMed - as supplied by publisher]
	Trends and risk factors associated with hepatitis A severity and mortality in French hospitals:â€‰a national population-based study, 2013 to 2024. Euro Surveill Roque-Afonso AM, Mouliade C, Parlati L, Goutté N, Figoni J, Bouam S, Sogni P, Mallet V, Demosthenes research group. PMID: 42825337 [PubMed - indexed for MEDLINE]
	HBsAg seroclearance with HBV DNA <100 IU/mL and long-term risks of adverse liver events, all-cause mortality, and cause-specific mortality in chronic hepatitis B: a prospective cohort study. Lancet Reg Health West Pac Zhang Y, Yao W, Jiang J, Qian J, Chen X, Jiang Q, Yan Y, Wang S, Bai H, He C, Zhu L, Jiang T, Hu Z, Shen H, Zhai X, Song C. PMID: 42825112 [PubMed]
	Rift Valley fever seroprevalence and associated factors in non-vaccinated livestock (cattle and small ruminants) in Arua, Lira and Apac districts, Uganda. BMC Vet Res Okello J, Nyakarahuka L, Agwai B, Okello IO, Opiyo FL, Ongebo I, Kakuru GB, Nanozi B, Namugenyi C, Tamale A, Okello W, Akello W, Oketch LF, Silvano O, Okello DN, Ogwal A, Odongo S, Omara R, Munyeme M, Kankya C, Breiman RF. PMID: 42823724 [PubMed - indexed for MEDLINE]
	Global, Regional and National Burden of Viral Hepatitis From 1990 to 2021 With Forecasts to 2046: Findings From the Global Burden of Disease Study 2021. J Viral Hepat Ren J, Ji R, Zhu Z, Ren X, Kong F, You H, Gao X, Wang F, Tang R, Liu X. PMID: 42820744 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 89179

Seite 1 von 4459



		Zeitfenster

Ironmedline

Das Fachportal für Eisenmangel >>

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung